1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Chromosomal Abnormalities
        1.2.3 X-linked Diseases
        1.2.4 Freeze Embryo Testing
        1.2.5 Aneuploidy Screening
        1.2.6 HLA
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Stem Cell Therapy
        1.3.3 IVF Prognosis
        1.3.4 Late-Onset Genetic Disorders
        1.3.5 Inherited Genetic Disease
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2017-2028)
    2.2 Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Region
        2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Region (2017-2022)
        2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2023-2028)
    2.3 Pre-Implantation Genetic Diagnosis (PGD) Market Dynamics
        2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Trends
        2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
        2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
        2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue
        3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2017-2022)
        3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2017-2022)
    3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
    3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
        3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2021
    3.5 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
    3.6 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    3.7 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
    4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2017-2022)
    4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2023-2028)
5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
    5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2017-2022)
    5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2017-2028)
    6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        6.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022)
        6.2.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028)
        6.2.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2017-2028)
    6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        6.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022)
        6.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028)
        6.3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2017-2028)
    6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        6.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022)
        6.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2017-2028)
    7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        7.2.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022)
        7.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028)
        7.2.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2017-2028)
    7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        7.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022)
        7.3.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028)
        7.3.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2017-2028)
    7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        7.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022)
        7.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size (2017-2028)
    8.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        8.2.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        8.3.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
        8.4.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2017-2028)
    9.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        9.2.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022)
        9.2.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028)
        9.2.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2017-2028)
    9.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        9.3.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022)
        9.3.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028)
        9.3.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2017-2028)
    9.4 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        9.4.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022)
        9.4.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size (2017-2028)
    10.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
        10.2.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
        10.3.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
        10.4.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Genea Limited
        11.2.1 Genea Limited Company Details
        11.2.2 Genea Limited Business Overview
        11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.2.5 Genea Limited Recent Developments
    11.3 Quest Diagnostics
        11.3.1 Quest Diagnostics Company Details
        11.3.2 Quest Diagnostics Business Overview
        11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.3.5 Quest Diagnostics Recent Developments
    11.4 Illumina, Inc.
        11.4.1 Illumina, Inc. Company Details
        11.4.2 Illumina, Inc. Business Overview
        11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.4.5 Illumina, Inc. Recent Developments
    11.5 Natera, Inc.
        11.5.1 Natera, Inc. Company Details
        11.5.2 Natera, Inc. Business Overview
        11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.5.5 Natera, Inc. Recent Developments
    11.6 Cooper Medical, Inc.
        11.6.1 Cooper Medical, Inc. Company Details
        11.6.2 Cooper Medical, Inc. Business Overview
        11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.6.5 Cooper Medical, Inc. Recent Developments
    11.7 LabCorp
        11.7.1 LabCorp Company Details
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.7.5 LabCorp Recent Developments
    11.8 California Pacific Medical Center (CPMC)
        11.8.1 California Pacific Medical Center (CPMC) Company Details
        11.8.2 California Pacific Medical Center (CPMC) Business Overview
        11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.8.5 California Pacific Medical Center (CPMC) Recent Developments
    11.9 Thermo Fisher Scientific Inc.
        11.9.1 Thermo Fisher Scientific Inc. Company Details
        11.9.2 Thermo Fisher Scientific Inc. Business Overview
        11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.9.5 Thermo Fisher Scientific Inc. Recent Developments
    11.10 IGENOMIX
        11.10.1 IGENOMIX Company Details
        11.10.2 IGENOMIX Business Overview
        11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.10.5 IGENOMIX Recent Developments
    11.11 Reproductive Genetic Innovations
        11.11.1 Reproductive Genetic Innovations Company Details
        11.11.2 Reproductive Genetic Innovations Business Overview
        11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.11.5 Reproductive Genetic Innovations Recent Developments
    11.12 CombiMatrix
        11.12.1 CombiMatrix Company Details
        11.12.2 CombiMatrix Business Overview
        11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
        11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
        11.12.5 CombiMatrix Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Chromosomal Abnormalities
    Table 3. Key Players of X-linked Diseases
    Table 4. Key Players of Freeze Embryo Testing
    Table 5. Key Players of Aneuploidy Screening
    Table 6. Key Players of HLA
    Table 7. Key Players of Others
    Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2017-2022)
    Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2023-2028)
    Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
    Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
    Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
    Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
    Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Players (2017-2022)
    Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2021)
    Table 21. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
    Table 25. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2017-2022)
    Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2023-2028)
    Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Application (2017-2022)
    Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Application (2023-2028)
    Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 68. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 69. Roche Recent Developments
    Table 70. Genea Limited Company Details
    Table 71. Genea Limited Business Overview
    Table 72. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 73. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 74. Genea Limited Recent Developments
    Table 75. Quest Diagnostics Company Details
    Table 76. Quest Diagnostics Business Overview
    Table 77. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 78. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 79. Quest Diagnostics Recent Developments
    Table 80. Illumina, Inc. Company Details
    Table 81. Illumina, Inc. Business Overview
    Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 83. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 84. Illumina, Inc. Recent Developments
    Table 85. Natera, Inc. Company Details
    Table 86. Natera, Inc. Business Overview
    Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 88. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 89. Natera, Inc. Recent Developments
    Table 90. Cooper Medical, Inc. Company Details
    Table 91. Cooper Medical, Inc. Business Overview
    Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 93. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 94. Cooper Medical, Inc. Recent Developments
    Table 95. LabCorp Company Details
    Table 96. LabCorp Business Overview
    Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 98. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 99. LabCorp Recent Developments
    Table 100. California Pacific Medical Center (CPMC) Company Details
    Table 101. California Pacific Medical Center (CPMC) Business Overview
    Table 102. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 103. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 104. California Pacific Medical Center (CPMC) Recent Developments
    Table 105. Thermo Fisher Scientific Inc. Company Details
    Table 106. Thermo Fisher Scientific Inc. Business Overview
    Table 107. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 108. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 109. Thermo Fisher Scientific Inc. Recent Developments
    Table 110. IGENOMIX Company Details
    Table 111. IGENOMIX Business Overview
    Table 112. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 113. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 114. IGENOMIX Recent Developments
    Table 115. Reproductive Genetic Innovations Company Details
    Table 116. Reproductive Genetic Innovations Business Overview
    Table 117. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 118. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 119. Reproductive Genetic Innovations Recent Developments
    Table 120. CombiMatrix Company Details
    Table 121. CombiMatrix Business Overview
    Table 122. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 123. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022) & (US$ Million)
    Table 124. CombiMatrix Recent Developments
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2021 VS 2028
    Figure 2. Chromosomal Abnormalities Features
    Figure 3. X-linked Diseases Features
    Figure 4. Freeze Embryo Testing Features
    Figure 5. Aneuploidy Screening Features
    Figure 6. HLA Features
    Figure 7. Others Features
    Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2021 VS 2028
    Figure 9. Stem Cell Therapy Case Studies
    Figure 10. IVF Prognosis Case Studies
    Figure 11. Late-Onset Genetic Disorders Case Studies
    Figure 12. Inherited Genetic Disease Case Studies
    Figure 13. Others Case Studies
    Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
    Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region: 2021 VS 2028
    Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2021
    Figure 19. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2021
    Figure 21. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
    Figure 23. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
    Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Country (2017-2028)
    Figure 25. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Country (2017-2028)
    Figure 31. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Region (2017-2028)
    Figure 41. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Country (2017-2028)
    Figure 51. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Country (2017-2028)
    Figure 57. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 61. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 62. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 63. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 64. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 65. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 66. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 67. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 68. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 69. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 70. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 71. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed